Over the past year we partnered with researchers in Kenya, the Philippines, South Africa, and Uganda to document, from a whole-of-health perspective, what we know about the nature, scale, and scope of COVID-19’s disruptions to essential health services in those countries, and the health effects of such disruptions. In a working paper released today, we build on a blog we published in March when we released working papers from each country team (the papers are available here: Kenya, the Philippines, South Africa, Uganda). In this new working paper, we summarize the results and lessons across the four countries in more detail. We also tie together many of the blogs we have written on this topic over the past year (this series of blogs can be found here).
CGD Policy Blogs
Vaccines have become a central instrument of our long-term response to the pandemic. Vaccination campaigns have now started around the world and will confer significant direct protection against infection, severe illness, and death to those inoculated. It may also protect against transmission, though robust evidence is yet to be confirmed.
The New C19economics.org: A Platform to Support the Generation and Use of Health Economics Research to Tackle COVID-19
Since the beginning of the COVID-19 outbreak, the scientific community has worked around the clock to produce evidence to support decision-makers in all aspects of pandemic management. As of April 2021, there are more than 78,000 articles published in peer reviewed journals and pre-prints (as indexed by collabovid.org). Those unprecedented collective research efforts have supported decisionmakers across the world on some of the toughest choices in decades, from closing economies, to procuring vaccines and medical supplies and equipment, and preparing for the uncertain year ahead.
The Indirect Health Effects of COVID-19: Emerging Findings from Kenya, the Philippines, South Africa, and Uganda
Much of the initial COVID response focused on limiting cases and deaths, without sufficient attention to the broader indirect impacts. A new CGD series investigates.
In this blog, we describe some major global efforts that examine whether essential health services have been disrupted during the pandemic, summarize what they tell us, and highlight some of the remaining gaps in our understanding and knowledge.
Prior to the pandemic, many low-and middle-income countries were on track to expand Universal Health Coverage. To what extent can LMICs still make real progress as their economies enter some of the most severe recessions in centuries?
A Platform to Support the Researchers and Decision-makers Generating and Using Health Economics Research to Tackle COVID-19
Since the beginning of the outbreak, the scientific community has worked around the clock to produce evidence to support decision-makers in all aspects of COVID management. However, health economics research has been largely missing from this growing literature. The C19economics.org platform has been launched to support policymakers (and their advisers) and researchers working on health economics for COVID, with a focus on LMICs.
Historically, donors and multilateral organisations have channelled funding in health through vertical disease programs, typically focussed on one disease area and a set of short- and medium-term objectives. We, and others, have argued that the “convergence” of verticals into a set of essential health benefits with pooled domestic and external funding to support its financing and delivery is the way ahead.
Since the beginning of the COVID-19 pandemic, reports about the indirect health impacts of COVID have been published in nearly all countries. In May we published a tool to estimate the net health impact of COVID-19 policies, and have updated the tool here.